- Report
- January 2025
- 152 Pages
Global
From €1992EUR$2,250USD£1,725GBP
- Report
- May 2025
- 196 Pages
Global
From €3139EUR$3,545USD£2,718GBP
€3487EUR$3,939USD£3,020GBP
- Report
- January 2025
- 175 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- July 2025
- 462 Pages
Global
From €5179EUR$5,850USD£4,486GBP
- Report
- October 2024
- 200 Pages
Global
From €3320EUR$3,750USD£2,875GBP
- Report
- February 2025
- 169 Pages
Latin America
From €7525EUR$8,500USD£6,518GBP
- Report
- October 2024
- 90 Pages
United States
From €5268EUR$5,950USD£4,562GBP
- Report
- June 2025
- 200 Pages
United States
From €2205EUR$2,490USD£1,909GBP
- Report
- April 2025
- 122 Pages
Europe
From €3010EUR$3,400USD£2,607GBP
€3541EUR$4,000USD£3,067GBP
- Report
- January 2024
- 492 Pages
Global
From €4117EUR$4,650USD£3,566GBP
- Report
- June 2022
- 257 Pages
Global
From €2324EUR$2,625USD£2,013GBP
€4648EUR$5,250USD£4,026GBP
- Report
- October 2023
- 154 Pages
Global
From €4117EUR$4,650USD£3,566GBP
- Report
- June 2023
- 180 Pages
Global
From €5268EUR$5,950USD£4,562GBP
- Report
- October 2023
- 120 Pages
India
From €5268EUR$5,950USD£4,562GBP
- Report
- November 2023
- 77 Pages
United States
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- September 2024
- 87 Pages
India
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- May 2024
- 180 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- May 2024
- 185 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- August 2022
- 115 Pages
Global
From €4205EUR$4,750USD£3,642GBP

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment.
The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more